Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Global Epinephrine market Analysis Report 2021 by Size, Share, Growth and Assessment to 2031

Published by top news

Posted on August 12, 2021

Featured image for article about Research Reports

Epinephrine is an active hormone produced by Adrenal Medulla. Epinephrine is responsible for stimulating both alpha and beta-adrenergic systems. Epinephrine helps in the gastrointestinal relaxation, systemic vasoconstriction, stimulation of the heart and dilates bronchi.

Epinephrine is generally found in the form of pre-filled syringes. Epinephrine is generally used for the treatment of Anaphylaxis, hypotension associated with septic shock, cardiac arrest, respiratory diseases and many more.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3222

Epinephrine injections are generally available as a prefilled automatic injection device containing a solution. The epinephrine can be administered by intravenous route, subcutaneous route or it can also be introduced intramuscularly. There are many key players in epinephrine market and they are mainly focusing on collaborations and partnerships with other companies, which is expected to increase the growth of the overall market.

Also, some of the companies are focusing on the innovation of new products. For example- Sandoz Inc., which is a division of Novartis, introduced SYMJEPI (epinephrine) 0.3 mg Injection for the urgent treatment of allergic reactions which also includes anaphylaxis. Also in 2018, Adamis Pharmaceuticals Corporation signed a distribution and commercialization agreement with Sandoz Inc. which is a division of the Novartis Group, for the marketing of Adamis’ Symjepi product for the emergency treatment of allergic reactions (Type I) including anaphylaxis.

Increasing pipeline epinephrine products, is one of the major factors, increasing the growth of the epinephrine market. Increasing air pollution, leading to an increased occurrence of respiratory diseases, can increase the growth of the epinephrine market. The increasing prevalence of cardiovascular diseases, cardiac arrest etc. can boost the growth of the epinephrine market. Increasing healthcare awareness is also expected to increase the growth of the epinephrine market. The epinephrine has a high adoption rate, hence, is expected to increase the growth of the overall market. Increased number of research and developmental activities and clinical trials, is one of the important factors, increasing the growth of the epinephrine market. The companies, manufacturing epinephrine, are focusing on many promotional strategies, which can boost the epinephrine market.

Epinephrine has some side effects, such as nausea, vomiting, headache etc., can hinder the growth of the epinephrine market.

The global Epinephrine market is segmented on basis of Route of administration, application, end user and geographic region:

Segmentation by Route of administration
- Intravenous
- Subcutaneous
- Intramuscular
Segmentation by Application
- Anaphylaxis
- Respiratory Disorders
- Cardiac Arrest
- Others
Segmentation by End User
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies

Get Access To TOC Covering 200+ Topics @ https://www.factmr.com/connectus/sample?flag=T&rep_id=3222

Based on the route of administration, the epinephrine market has been segmented into intravenous, subcutaneous and intramuscular. Intravenous route of administration is expected to hold the largest revenue share in the epinephrine market, as it is primarily referred by most of the physicians. The epinephrine market has also been segmented based on the applications, and Anaphylaxis & Cardiac arrest is expected to hold a large revenue share in the overall epinephrine market. Based on the end user, the epinephrine market has been segmented into hospital pharmacies, retail pharmacies, various drug stores and also online pharmacies. Retail and hospital pharmacies are expected to show the largest market share in the epinephrine market.

Based on geography, the global Epinephrine market has been divided into a few key regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa. North America, specifically, U.S. is expected to register large revenue shares in global Epinephrine market because of the advanced healthcare facilities and treatment procedures followed by Europe and Asia-Pacific. Europe is expected to hold the second largest market share because of the increasing population. The Asia Pacific can also show a large revenue share in the epinephrine market because of the increasing healthcare awareness and increasing research and developmental activities.

There are many companies manufacturing epinephrine. Some of the big pharmaceutical companies involved in the manufacture of epinephrine are Mylan Pharmaceuticals, Pfizer, Bausch Health Companies, Sanofi, Impax Laboratories LLC, Teva Pharmaceutical Industries Ltd., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Lincoln Medical Centre Ltd. Hospira, and Clint Pharmaceuticals.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates